CLINICAL_TRIALS
trial_result
· 2013-07-02
Clinical Trial Update: Evaluation of the GORE® ACUSEAL Vascular Graft for Hemodialysis Access [Phase 2, Phase 3]
Summary
Phase 2/3 trial evaluating the GORE ACUSEAL Vascular Graft for hemodialysis access has completed with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: W.L.Gore & Associates | Conditions: End Stage Renal Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2013-07-02